U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770789) titled 'Clinical Trial to Study the Efficacy and Safety of Rejeunesse Shape With Lidocaine (HA Filler) in Treating Healthy Subjects' on Aug. 10.

Brief Summary: Intend to prove the non-inferiority of Rejeunesse against the comparing medical device of Restylane Perlane in terms of improvement, efficacy, and safety of nasolabial fold on the face

Study Start Date: Feb. 15, 2016

Study Type: INTERVENTIONAL

Condition: Nasolabial Fold Correction

Intervention: DEVICE: Rejeunesse

The clinical medical device, Rejeunesse, is a cross-lined HA hydrogel made by using the cross-linker of 1, 4-butandiol diglycidyl ether (BDDE) with low toxicity from ...